BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20932226)

  • 21. Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.
    Perrella A; Arenga G; Pisaniello D; Rampone B; Di Costanzo GG; Atripaldi L; Esposito C; Di Florio E; Perrella O; Cuomo O
    Transplant Proc; 2009 Jun; 41(5):1761-6. PubMed ID: 19545723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.
    Rehermann B
    Semin Liver Dis; 2007 May; 27(2):152-60. PubMed ID: 17520515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.
    Chen Y; Wei H; Sun R; Tian Z
    Int Immunopharmacol; 2005 Dec; 5(13-14):1839-52. PubMed ID: 16275620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
    Bortolami M; Kotsafti A; Cardin R; Farinati F
    J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
    Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
    Kondo Y; Ueno Y; Kobayashi K; Kakazu E; Shiina M; Inoue J; Tamai K; Wakui Y; Tanaka Y; Ninomiya M; Obara N; Fukushima K; Ishii M; Kobayashi T; Niitsuma H; Kon S; Shimosegawa T
    J Infect Dis; 2010 Jul; 202(2):202-13. PubMed ID: 20533879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation.
    Shiffman ML
    Liver Transpl; 2003 Nov; 9(11):S14-20. PubMed ID: 14586890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.
    Romani F; Belli LS; Rondinara GF; DeCarlis L; Rimoldi P; Riolo F; Bellati G; Ideo G; Belli L
    J Am Coll Surg; 1994 Apr; 178(4):379-84. PubMed ID: 8149037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells.
    Ciuffreda D; Codarri L; Buhler L; Vallotton L; Giostra E; Mentha G; Morel P; Pantaleo G; Pascual M
    Liver Transpl; 2010 Jan; 16(1):49-55. PubMed ID: 19866484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes of immune function in patients with liver cirrhosis after splenectomy combined with resection of hepatocellular carcinoma.
    Cao ZX; Chen XP; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):562-5. PubMed ID: 14627520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients.
    Stoop JN; Claassen MA; Woltman AM; Binda RS; Kuipers EJ; Janssen HL; van der Molen RG; Boonstra A
    Clin Immunol; 2008 Dec; 129(3):419-27. PubMed ID: 18823821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
    Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
    Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.